Anna Eshoo: “If we are going to work on reforms, let's work on reforms.”

I see, as I expressed to you when we spoke, a disconnect between CMS, the FDA, and the VA on new treatments for mild Alzheimer's.

I rise this evening to give valedictory remarks as my service as a United States Representative comes to a close. Nearly 32 years ago, I arrived in this Chamber after the people of the most distinguished congressional district in our…

The PBM Accountability Act will finally shed a light on the opaque drug pricing system.

I think that the committee needs to take that into consideration.